Amyotrophic Lateral Sclerosis
📧 Sign up to get email alerts when something new happens for Amyotrophic Lateral Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Cervical Electrical Stimulation for ALS [NA]
A completed clinical trial assessing cervical electrical stimulation for amyotrophic lateral sclerosis; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral Sclerosis [Phase 2]
A Phase 2 clinical trial evaluating clenbuterol for motor function in individuals with amyotrophic lateral sclerosis has completed and poste…
-
CLINICAL_TRIALS trial_result · 2022-08-29Clinical Trial Update: Safety Study of Oral Edaravone Administered in Subjects With ALS [Phase 3]
Phase 3 safety study of oral edaravone in people with amyotrophic lateral sclerosis has completed and results are posted.
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Physiological Flow of Liquids Used in Dysphagia Management (Neuro)
Completed clinical trial evaluating physiological flow of liquids used in dysphagia management in ALS and Parkinson disease patients; result…
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx [NA]
A completed clinical trial evaluating Transmembrane Electromyography (TM-EMG) for assessing neuromuscular function in the oropharynx with re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-06Clinical Trial Update: NF-κB Inhibition in Amyotrophic Lateral Sclerosis [Phase 2]
Phase 2 clinical trial exploring NF-κB inhibition as a potential therapy for amyotrophic lateral sclerosis.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS [Phase 1, Phase 2]
A clinical trial evaluating mesenchymal stem cells for the immune system in patients with amyotrophic lateral sclerosis (ALS) across Phase 1…
-
CLINICAL_TRIALS trial_result · 2022-04-21Clinical Trial Update: Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis [Phase 1, Phase 2]
Phase 1/2 trial investigating Supported Treadmill Ambulation Training (STAT) for patients with amyotrophic lateral sclerosis (ALS).
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Phase 3 Extension Study of Dexpramipexole in ALS [Phase 3]
Phase 3 extension study update for dexpramipexole in ALS; study terminated with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral [Phase 1, Phase 2]
A multicenter Phase I/II trial evaluating the safety of mesenchymal stem cells in patients with amyotrophic lateral sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Treatment Continuation Study for Patients With ALS/MND Who Completed Study CMD-2019-001 [Phase 2]
Phase 2 treatment continuation study for ALS/MND patients who completed CMD-2019-001 has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: ALS Treatment Extension Study [Phase 1, Phase 2]
Clinical trial update for an ALS treatment extension study spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
Phase 2 clinical trial update for ibudilast (MN-166) in subjects with amyotrophic lateral sclerosis has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: ALS and Airway Clearance (ALSAC) Therapy [NA]
Completed clinical trial investigating ALS and airway clearance therapy (ALSAC) for amyotrophic lateral sclerosis with respiratory muscle we…
-
CLINICAL_TRIALS trial_result · 2021-10-20Clinical Trial Update: Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
Phase 2 trial of glatiramer acetate in amyotrophic lateral sclerosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: T-regulatory Cells in ALS [Phase 2]
Phase 2 clinical trial update investigating T-regulatory cells in Amyotrophic Lateral Sclerosis is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis [Phase 2]
Phase 2 clinical trial update on safety and tolerability of high-dose biotin in patients with amyotrophic lateral sclerosis.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS [Phase 3]
Phase 3 trial investigating oral levosimendan (ODM-109) for respiratory function in amyotrophic lateral sclerosis has completed with results…
-
CLINICAL_TRIALS trial_result · 2021-08-18Clinical Trial Update: Low Dose IL-2 in the Treatment of Immune-associated ALS Syndrome [Phase 2]
Phase 2 trial evaluating low-dose interleukin-2 for immune-associated amyotrophic lateral sclerosis.
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211) [Phase 2]
Phase 2 open-label extension study assessing safety and tolerability of KNS-760704 in amyotrophic lateral sclerosis completed with results p…
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
Phase 2 trial of AMX0035 in amyotrophic lateral sclerosis completed; results were posted in August 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: The Treatment of Amyotrophic Lateral Sclerosis With Huollingshengji Granules [Phase 2, Phase 3]
Phase 2/3 trial update for Huollingshengji granules in amyotrophic lateral sclerosis is reported, with current status unknown.
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
Phase 2 safety and tolerability study of KNS-760704 in amyotrophic lateral sclerosis (ALS) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-06Clinical Trial Update: Efficacy and Safety of Nitrazine in the Treatment of ALS [Phase 2]
Phase 2 clinical trial update on Nitrazine for amyotrophic lateral sclerosis, reporting on efficacy and safety.